Trials / Completed
CompletedNCT01854944
PET Trial to Assess the Receptor Occupancy of Brexpiprazole in Adult Subjects With Schizophrenia
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 12 (actual)
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine how low and high does of brexpiprazole binds to certain receptors in the brain. This will be determined by PET scans taken pre-dose and post-dose.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Brexpiprazole 1mg to 4mg |
Timeline
- Start date
- 2013-09-01
- Primary completion
- 2014-07-01
- Completion
- 2014-08-01
- First posted
- 2013-05-16
- Last updated
- 2016-02-04
- Results posted
- 2016-02-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01854944. Inclusion in this directory is not an endorsement.